Avicanna Inc (TSX:AVCN, OTCQX:AVCNF) announced that it has entered into a Master Service Agreement (MSA) with Northern Green Canada (NGC) a federally-licensed cannabis producer, to operationalize the MyMedi.ca medical cannabis care platform’s logistics and fulfilment infrastructure beginning in the second quarter of 2023.
The biopharmaceutical company said the MyMedi.ca platform will provide Medical Cannabis by Shoppers patients a complete medical cannabis care platform including curated products and services.
“NGC’s established infrastructure and quality assurance expertise gives us confidence that they are the right choice as we aim to build upon the foundation initially developed by the Medical Cannabis by Shoppers team and further establish confidence in medical cannabis solutions by providing education, expanding coverage, and striving towards increased consistency in services,” Avicanna CEO Aras Azadian said in a statement.
Avicanna noted that NGC will provide the MyMedi.ca medical cannabis care platform with regulatory support and access to appropriate Health Canada licenses in addition to services related to inventory management and quality assurance, establishing MyMedi.ca as a comprehensive resource to support the medical community and the tens of thousands of patients currently authorized to access the Medical Cannabis by Shoppers platform.
The company added that NGC will also contribute to the MyMedi.ca medical cannabis care platform’s formulary of products with its own EU GMP-certified proprietary genetics and finished products.
Shoppers Drug Mart has partnered with Avicanna to transition its Medical Cannabis by Shoppers business and provide its patients access to a complete medical cannabis platform through MyMedi.ca.
Avicanna is a commercial-stage international biopharmaceutical company focused on the advancement and commercialization of evidence-based cannabinoid-based products for the global medical and pharmaceutical market segments.
Contact Sean at sean@proactiveinvestors.com